Charles J Dockendorff - Net Worth and Insider Trading
Charles J Dockendorff Net Worth
The estimated net worth of Charles J Dockendorff is at least $17 Million dollars as of 2024-11-08. Charles J Dockendorff is the Director of Keysight Technologies Inc and owns about 52,423 shares of Keysight Technologies Inc (KEYS) stock worth over $9 Million. Charles J Dockendorff is the Director of Boston Scientific Corp and owns about 60,002 shares of Boston Scientific Corp (BSX) stock worth over $5 Million. Charles J Dockendorff is also the Director of Haemonetics Corp and owns about 20,141 shares of Haemonetics Corp (HAE) stock worth over $2 Million. Besides these, Charles J Dockendorff also holds Hologic Inc (HOLX) . Details can be seen in Charles J Dockendorff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles J Dockendorff has not made any transactions after 2024-05-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles J Dockendorff
Charles J Dockendorff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles J Dockendorff owns 4 companies in total, including Haemonetics Corp (HAE) , Boston Scientific Corp (BSX) , and Keysight Technologies Inc (KEYS) among others .
Click here to see the complete history of Charles J Dockendorff’s form 4 insider trades.
Insider Ownership Summary of Charles J Dockendorff
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HAE | Haemonetics Corp | 2023-09-05 | director |
BSX | Boston Scientific Corp | 2024-05-07 | director |
KEYS | Keysight Technologies Inc | 2022-12-13 | director |
2024-03-08 | director |
Charles J Dockendorff Latest Holdings Summary
Charles J Dockendorff currently owns a total of 4 stocks. Among these stocks, Charles J Dockendorff owns 52,423 shares of Keysight Technologies Inc (KEYS) as of December 13, 2022, with a value of $9 Million and a weighting of 51.06%. Charles J Dockendorff owns 60,002 shares of Boston Scientific Corp (BSX) as of May 7, 2024, with a value of $5 Million and a weighting of 30.74%. Charles J Dockendorff also owns 20,141 shares of Haemonetics Corp (HAE) as of September 5, 2023, with a value of $2 Million and a weighting of 10.28%. The other 1 stocks Hologic Inc (HOLX) have a combined weighting of 7.92% among all his current holdings.
Latest Holdings of Charles J Dockendorff
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KEYS | Keysight Technologies Inc | 2022-12-13 | 52,423 | 165.18 | 8,659,231 |
BSX | Boston Scientific Corp | 2024-05-07 | 60,002 | 86.88 | 5,212,974 |
HAE | Haemonetics Corp | 2023-09-05 | 20,141 | 86.53 | 1,742,801 |
HOLX | Hologic Inc | 2024-03-08 | 16,942 | 79.29 | 1,343,331 |
Holding Weightings of Charles J Dockendorff
Charles J Dockendorff Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles J Dockendorff has made a total of 1 transactions in Keysight Technologies Inc (KEYS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Keysight Technologies Inc is the sale of 3,257 shares on December 13, 2022, which brought Charles J Dockendorff around $602,740.
According to the SEC Form 4 filings, Charles J Dockendorff has made a total of 2 transactions in Boston Scientific Corp (BSX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Boston Scientific Corp is the sale of 3,946 shares on May 7, 2024, which brought Charles J Dockendorff around $286,874.
According to the SEC Form 4 filings, Charles J Dockendorff has made a total of 2 transactions in Haemonetics Corp (HAE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Haemonetics Corp is the sale of 10,215 shares on September 5, 2023, which brought Charles J Dockendorff around $895,651.
More details on Charles J Dockendorff's insider transactions can be found in the Insider Trading History of Charles J Dockendorff table.Insider Trading History of Charles J Dockendorff
- 1
Charles J Dockendorff Trading Performance
GuruFocus tracks the stock performance after each of Charles J Dockendorff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles J Dockendorff is 14.28%. GuruFocus also compares Charles J Dockendorff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles J Dockendorff within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles J Dockendorff's insider trading performs compared to the benchmark.
Performance of Charles J Dockendorff
Charles J Dockendorff Ownership Network
Ownership Network List of Charles J Dockendorff
Ownership Network Relation of Charles J Dockendorff
Charles J Dockendorff Owned Company Details
What does Haemonetics Corp do?
Who are the key executives at Haemonetics Corp?
Charles J Dockendorff is the director of Haemonetics Corp. Other key executives at Haemonetics Corp include President & Global Hospital Stewart W Strong , EVP & Chief Technology Officer Anila Lingamneni , and EVP and General Counsel Michelle L Basil .
Haemonetics Corp (HAE) Insider Trades Summary
Over the past 18 months, Charles J Dockendorff made 1 insider transaction in Haemonetics Corp (HAE) with a net sale of 10,215. Other recent insider transactions involving Haemonetics Corp (HAE) include a net sale of 17,354 shares made by Stewart W Strong , a net sale of 9,129 shares made by Anila Lingamneni , and a net sale of 16,652 shares made by Michelle L Basil .
In summary, during the past 3 months, insiders sold 0 shares of Haemonetics Corp (HAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 60,857 shares of Haemonetics Corp (HAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 60,857 shares.
Haemonetics Corp (HAE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Haemonetics Corp Insider Transactions
Charles J Dockendorff Mailing Address
Above is the net worth, insider trading, and ownership report for Charles J Dockendorff. You might contact Charles J Dockendorff via mailing address: Covidien Ltd., 15 Hampshire Street, Mansfield Ma 02048.